These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 23329388)
1. Pretreatment of infant formula with sodium polystyrene sulfonate : focus on optimal amount and contact time. Cameron JC; Kennedy D; Feber J; Wong E; Geier P; Vaillancourt R Paediatr Drugs; 2013 Feb; 15(1):43-8. PubMed ID: 23329388 [TBL] [Abstract][Full Text] [Related]
2. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency. Thompson K; Flynn J; Okamura D; Zhou L J Ren Nutr; 2013 Sep; 23(5):333-9. PubMed ID: 23707305 [TBL] [Abstract][Full Text] [Related]
3. [Case report of an infant hyperkalemia: Suggestion of a hospital procedure for the milk pretreatment with sodium polystyrene sulfonate resin]. Robert S; Nisse YE; Henn-Ménétré S; Vrillon I; Demoré B Ann Pharm Fr; 2020 Jul; 78(4):287-293. PubMed ID: 32439127 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia. Mistry M; Shea A; Giguère P; Nguyen ML Ann Pharmacother; 2016 Jun; 50(6):455-62. PubMed ID: 27048188 [TBL] [Abstract][Full Text] [Related]
5. Polysulfonate Resins in Hyperkalemia: A Systematic Review. Wong SWS; Zhang G; Norman P; Welihinda H; Wijeratne DT Can J Kidney Health Dis; 2020; 7():2054358120965838. PubMed ID: 33240515 [TBL] [Abstract][Full Text] [Related]
6. Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate. Fassinger N; Dabbagh S; Mukhopadhyay S; Lee DY Adv Perit Dial; 1998; 14():274-7. PubMed ID: 10649740 [TBL] [Abstract][Full Text] [Related]
7. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate. Lee J; Moffett BS Pediatr Nephrol; 2016 Nov; 31(11):2113-7. PubMed ID: 27215929 [TBL] [Abstract][Full Text] [Related]
8. Renal formulas pretreated with medications alters the nutrient profile. Taylor JM; Oladitan L; Carlson S; Hamilton-Reeves JM Pediatr Nephrol; 2015 Oct; 30(10):1815-23. PubMed ID: 25930981 [TBL] [Abstract][Full Text] [Related]
9. Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake. Bunchman TE; Wood EG; Schenck MH; Weaver KA; Klein BL; Lynch RE Pediatr Nephrol; 1991 Jan; 5(1):29-32. PubMed ID: 2025533 [TBL] [Abstract][Full Text] [Related]
10. Sodium polystyrene sulfonate used to reduce the potassium content of a high-protein enteral formula: a quantitative analysis. Rivard AL; Raup SM; Beilman GJ JPEN J Parenter Enteral Nutr; 2004; 28(2):76-8. PubMed ID: 15080600 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease. Georgianos PI; Liampas I; Kyriakou A; Vaios V; Raptis V; Savvidis N; Sioulis A; Liakopoulos V; Balaskas EV; Zebekakis PE Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620 [TBL] [Abstract][Full Text] [Related]
12. Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy. Chernin G; Gal-Oz A; Ben-Assa E; Schwartz IF; Weinstein T; Schwartz D; Silverberg DS Clin Cardiol; 2012 Jan; 35(1):32-6. PubMed ID: 22057933 [TBL] [Abstract][Full Text] [Related]
13. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study. Hagan AE; Farrington CA; Wall GC; Belz MM Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776 [TBL] [Abstract][Full Text] [Related]
14. Pretreatment of enteral nutrition with sodium polystyrene sulfonate: effective, but beware the high prevalence of electrolyte derangements in clinical practice. Le Palma K; Pavlick ER; Copelovitch L Clin Kidney J; 2018 Apr; 11(2):166-171. PubMed ID: 29644055 [TBL] [Abstract][Full Text] [Related]
15. Treatment of infant formula with patiromer dose dependently decreases potassium concentration. Paloian NJ; Bowman B; Bartosh SM Pediatr Nephrol; 2019 Aug; 34(8):1395-1401. PubMed ID: 30963285 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia. Batterink J; Lin J; Au-Yeung SH; Cessford T Can J Hosp Pharm; 2015; 68(4):296-303. PubMed ID: 26327703 [TBL] [Abstract][Full Text] [Related]
17. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD. Lepage L; Dufour AC; Doiron J; Handfield K; Desforges K; Bell R; Vallée M; Savoie M; Perreault S; Laurin LP; Pichette V; Lafrance JP Clin J Am Soc Nephrol; 2015 Dec; 10(12):2136-42. PubMed ID: 26576619 [TBL] [Abstract][Full Text] [Related]
18. The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia. Kessler C; Ng J; Valdez K; Xie H; Geiger B J Hosp Med; 2011 Mar; 6(3):136-40. PubMed ID: 21387549 [TBL] [Abstract][Full Text] [Related]
19. A case of 1-month-old female infant delaying peritoneal dialysis introduction by low-potassium anti-allergic formula treated with sodium polystyrene sulfonate. Iida T; Nishimura T; Mizukoshi Y; Tsuruoka T; Hisano M CEN Case Rep; 2022 Nov; 11(4):482-486. PubMed ID: 35441977 [TBL] [Abstract][Full Text] [Related]
20. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. Watson M; Abbott KC; Yuan CM Clin J Am Soc Nephrol; 2010 Oct; 5(10):1723-6. PubMed ID: 20798253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]